- Home
- AGYS vs XENE Comparison
AGYS vs XENE Comparison
Compare AGYS & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGYS | XENE |
|---|---|---|
| Founded | 1963 | 1996 |
| Country | United States | Canada |
| Employees | 2413 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AGYS | XENE |
|---|---|---|
| Price | $120.55 | $35.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 19 |
| Target Price | ★ $134.50 | $72.43 |
| AVG Volume (30 Days) | 214.8K | ★ 1.7M |
| Earning Date | 10-26-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.07 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $319,312,000.00 | $311,000.00 |
| Revenue This Year | $16.13 | N/A |
| Revenue Next Year | $16.93 | $2,045.70 |
| P/E Ratio | $373.94 | ★ N/A |
| Revenue Growth | ★ 15.85 | N/A |
| 52 Week Low | $61.50 | $33.38 |
| 52 Week High | $144.82 | $72.66 |
Technical Indicators
Market Signals| Indicator | AGYS | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 70.78 | 34.04 |
| Support Level | $103.53 | $33.38 |
| Resistance Level | $121.59 | $43.68 |
| Average True Range (ATR) | 3.84 | 1.24 |
| MACD | 2.01 | 0.91 |
| Stochastic Oscillator | 93.30 | 48.30 |
Price Performance
Historical ComparisonAbout AGYS Agilysys Inc.
Agilysys Inc is engaged in hospitality software, delivering cloud-native SaaS and on-premise solutions for hotels, multi-amenity resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It operates across the Americas, Europe, the Middle East, Africa, Asia-Pacific, and India with headquarters located in Alpharetta, GA. The Company has one reportable segment serving the global hospitality industry.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.